Complete Question Bank | Study Guide PDF
1. In a scenario where a 12-year-old girl with acute lymphoblastic leukemia is in
shock, how would you determine the appropriate volume of normal saline to
administer?
Administer a fixed volume of 500 mL regardless of weight.
Calculate 20 mL/kg based on her weight.
Administer 10 mL/kg without considering her weight.
Use a standard adult dosage of 30 mL.
2. What is the first-line medication for a pediatric patient presenting with stridor
due to respiratory distress?
Aspirin
Racemic epinephrine
Atropine
Albuterol
3. In a scenario where a 2-year-old child presents with grunting and decreased
oxygen saturation, what should be the immediate course of action?
Administer a cough suppressant and monitor.
Give the child fluids and observe for improvement.
Wait for the child to calm down before reassessing.
Provide supplemental oxygen and prepare for further respiratory
support.
,4. In a scenario where a pediatric patient requires CPR, how would you ensure
high-quality compressions are being performed?
By performing compressions quickly without breaks.
By using a pediatric bag-mask device during compressions.
By monitoring for complete chest wall recoil and maintaining the
correct compression depth and rate.
By alternating compressions with rescue breaths every 30 seconds.
5. A 3 year old child has had diarrhea and vomiting for the past three days
secondary to a viral infection. Today his mother calls 911 because he has
become lethargic. On arrival, you find the child to be only minimally
responsive to you when you stick the IV in his arm. His blood pressure is low
and his heart rate is very fast. Which of the following BEST describes this type
of shock?
Neurogenic
Hypovolemic
Cadiogenic
Distributive
6. In a scenario where a 3-month-old infant presents with severe dehydration
and requires immediate fluid resuscitation, how would you calculate the total
volume needed if the infant weighs 6 kg?
120 mL
60 mL
180 mL
90 mL
,7. A 5-year-old child is brought to the emergency department by ambulance
after being involved in a motor vehicle collision. You are using the primary
assessment to evaluate the child. When assessing the child's neurologic
status, you note that he has spontaneous eye opening, is fully oriented, and is
able to follow commands. How would you document this child's AVPU (Alert,
Voice, Painful, Unresponsive) Pediatric Response Scale finding?
Voice
Unresponsive
Painful
Alert
8. You are caring for a 5-year-old boy with a 4-day history of high fever and
cough. He is having increasing lethargy, grunting, and sleepiness. Now he is
difficult to arouse and is unresponsive to voice commands. His O2 sat is 72%
on room air and 89% when on an NRB O2 mask. He has shallow respirations,
with a respiratory rate of 38/min. Auscultation of the lungs reveals bilateral
crackles. Which medication would be most appropriate?
An antibiotic
A vasopressor
A bronchodilator
A corticosteroid
9. What is the recommended compression to breath ratio for 1-rescuer infant
CPR?
5:1
10:1
15:2
, 30:2
10. Describe the importance of early intervention in managing a pediatric
patient with acute lymphoblastic leukemia during an emergency situation.
Early intervention is unnecessary if the patient is stable.
Early intervention is crucial as it can stabilize the patient and
address complications related to the leukemia.
Early intervention is only required after fluid resuscitation.
Early intervention only focuses on pain management.
11. During the initial assessment, you find that an infant is unresponsive and has
HR of less than 60/min. What should be your next action?
obtain BGL
begin rescue breathing
stimulate the infant
begin CPR
12. Why is the assessment of the severity of a patient's condition crucial in
pediatric emergencies, particularly for a child with acute lymphoblastic
leukemia?
It is used to assess the effectiveness of previous treatments.
It provides insight into the child's psychological state.
It helps prioritize interventions based on the urgency of the child's
medical needs.
It determines the child's eligibility for clinical trials.